RIYADH: South Korean SK Bioscience Company has topped the list of the world’s best-performing IPO in 2021 after raising more than $1 billion. The biopharmaceutical firm, which is a local COVID-19 vaccine production partner with AstraZeneca, led a ranking dominated by listings from its home country, according to an analysis by Bloomberg. The IPO raised $1.3 billion for SK